International generic name

Combined product

Drug form and composition

Ointment. One gram ointment contains: 30 mg Ephedrine hydrochloride, 50 mg Sulfathiazole, 75 mg Sodium hydrogen carbonate.

Indications

Acute and chronic rhinitis; rhinosinusitis.

Dosage and administration

The drug is used topically. After cleaning the nasal discharge, the ointment is applied in each nostril 3 - 4 times daily.

Contraindications

Rhinolex is not used in cases of hypersensitivity to some of the drug ingredients.

Special warnings and precautions

The drug should be used with caution in cases of severe structural heart diseases and advanced atherosclerosis, angina pectoris, insomnia, and hyperthyroidism.

Drug interactions

No clinically significant drug interactions have been observed.

Adverse reactions

In susceptible patients and after administration of high drug doses, transitory mild tremor, tachycardia, increased sweating, and rash can be observed. In children, ephedrine in the drug can induce insomnia and agitation.

Pharmacological mechanisms

Rhinolex is a combined drug. The nasal mucosa shows a very good tolerance to this drug, with fast vasoconstrictive and antiseptic effect. Ephedrine in the drug has a sympathomimetic vasoconstrictive effect, reduces the swelling, decreases the nasal discharge and improves the breathing. Sulfathiazole possesses a wide spectrum antimicrobial action. The third ingredient of the drug, sodium hydrogen carbonate, facilitates the liquefaction and elimination of the discharge from the nasal cavity.

Supplied

Tubes, containing 18 g of ointment.

Expiry

2 years